← back to search

Chantal Thys

KU Leuven · BE
Area of research
Hematology · Genetics
Research interest
Research interests include Platelet Disorders and Treatments, Genomics and Rare Diseases, Blood disorders and treatments, and Antiplatelet Therapy and Cardiovascular Diseases.
h-index
33
citations
4,540
works
107
NIH funding
primary concept
Medicine
email

Recent publications

Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders
Nature Medicine 2024cited by 84position: middledoi
Genetic association analysis of 77,539 genomes reveals rare disease etiologies
Nature Medicine 2023cited by 78position: middledoi
Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience
Journal of Thrombosis and Haemostasis 2023cited by 23position: middledoi
Whole-genome sequencing of patients with rare diseases in a national health system
Nature 2020cited by 577position: middledoi
Germline selection shapes human mitochondrial DNA diversity
Science 2019cited by 250position: middledoi
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders
Blood 2019cited by 217position: middledoi
Germline mutations in the transcription factor IKZF5 cause thrombocytopenia
Blood 2019cited by 40position: middledoi
Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome
Journal of Allergy and Clinical Immunology 2018cited by 51position: middledoi
Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder
Blood Advances 2018cited by 40position: middledoi
Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia
Haematologica 2018cited by 40position: middledoi
The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer
Haematologica 2017cited by 34position: middledoi
A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss
Blood 2016cited by 155position: middledoi
A dominant gain-of-function mutation in universal tyrosine kinase <i>SRC</i> causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
Science Translational Medicine 2016cited by 143position: middledoi
Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome
Nature Genetics 2012cited by 426position: middledoi
NPC1 defect results in abnormal platelet formation and function: studies in Niemann–Pick disease type C1 patients and zebrafish
Human Molecular Genetics 2012cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kathleen Freson · KU Leuven7 papers (2012–2024)Chris Van Geet · KU Leuven5 papers (2012–2023)Ernest Turro · University Medical Center Hamburg-Eppendorf3 papers (2018–2024)Willem H. Ouwehand · University College Hospital2 papers (2018–2018)Andrew Mumford · North Bristol NHS Trust2 papers (2018–2024)Keith Gomez · KU Leuven2 papers (2018–2018)Veerle Labarque · KU Leuven2 papers (2018–2023)Sofia Papadia · University of Edinburgh2 papers (2018–2018)Kathelijne Peerlinck · KU Leuven2 papers (2017–2023)Christine Wittevrongel · KU Leuven2 papers (2012–2017)Jessica Heremans · KU Leuven2 papers (2018–2018)Daniel Greene · Cambridge University Hospitals NHS Foundation Trust2 papers (2018–2018)Olga Shamardina · Cambridge University Health Partners1 papers (2018–2018)Carine Wouters · KU Leuven1 papers (2018–2018)Karen Willekens · KU Leuven1 papers (2023–2023) · 1 papers (2018–2018)Deborah Whitehorn · Cambridge University Hospitals NHS Foundation Trust1 papers (2018–2018)Luc Régal · KU Leuven1 papers (2012–2012)Stéphanie Humblet‐Baron · KU Leuven1 papers (2018–2018) · 1 papers (2018–2018)